Menu

Battling the Bugs: Mitigating Cell Culture Contamination

The Scientist is bringing together experts from industry to discuss issues with cell culture contamination on small and large scales

Sep 27, 2019
The Scientist Creative Services Team

FREE Webinar

Thursday, November 7, 2019
2:30 - 4:00  PM Eastern Time

Register Now

Ensuring cell culture sterility is essential in small and large bioprocesses. Microbial contamination from bacteria, viruses, and fungi can spread among experiments and workflows—wasting time, resources, and precious cell lines. These unwanted organisms can change the growth rate, morphology, and gene expression of cultured cells. Additionally, contaminants in biotherapeutics put patients directly at risk. Therefore, methods to prevent and remove contaminants should be a main consideration for every lab. The Scientist is bringing together experts from industry to discuss issues with cell culture contamination on small and large scales. The experts will highlight the effects of contaminants, examine prevention and mitigation strategies for unwanted microbial growth, and answer questions from webinar attendees.

Topics to be Covered

  • The risks and prevention of microbial contamination in recombinant protein, cell, and gene therapy products
  • Mycoplasma: the smallest bug, the biggest problem

Register Now

Meet the Speakers:

Barbara J. Potts, PhD
Senior Consultant
Potts and Nelson Consulting


Nick Amiss
Product Steward, Oxford Biomedica
Science Outreach Speaker



November 2019

Oceanic Connections

Biologists consider the movements of marine animals

Marketplace

Sponsored Product Updates

TTP plc Desktop Biology enables development and manufacture of DnaNudge technology
TTP plc Desktop Biology enables development and manufacture of DnaNudge technology
·        Novel multiplex technology developed to help consumers make healthier choices based on their genetic profile·        TTP involved with all aspects of product development, from initial concept to prototype testing and manufacture·        Culmination of technology and product development partnership spanning just over 3 years
Targos and Ultivue partner to incorporate highly standardized UltiMapper™ tissue multiplex phenotypic assays in support of clinical research services
Targos and Ultivue partner to incorporate highly standardized UltiMapper™ tissue multiplex phenotypic assays in support of clinical research services
Targos Molecular Pathology GmbH, a market leader in clinical biomarker services announced today a technology partnership with Ultivue, the innovation leader in multiplex tissue biomarker assays, to offer the biopharmaceutical industry new capabilities to improve the characterization of cancer patients’ samples selected for clinical research programs. 
MicroMedicine to Launch Automated, Microfluidics-based Cell Isolation Technology at the Society for Immunotherapy of Cancer (SITC) Meeting
MicroMedicine to Launch Automated, Microfluidics-based Cell Isolation Technology at the Society for Immunotherapy of Cancer (SITC) Meeting
MicroMedicine, Inc., a life sciences technology company, today announced that it will be launching its patented one-of-a-kind white blood cell isolation technology, the Sorterra™ Cell Isolation System, at the 34th Annual SITC Conference.
Measuring the Affinity of Challenging Protein Targets
Measuring the Affinity of Challenging Protein Targets
Watch this webinar from Fluidic Analytics to learn more about microfluidic diffusional sizing, how it can be used to measure not only protein size and binding affinity, but also stoichiometry and protein conformation in protein-protein, protein-antibody, and protein-aptamer interactions!